ESR1 and breast carcinoma: Emerging evidence has also shown that central adiposity is more strongly associated with estrogen receptor (ER)-negative/progesterone receptor (PR)-negative tumors than ER-positive/PR-positive tumors for premenopausal breast cancers [18,19,20].